BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 8, 2025
See today's BioWorld Asia
Home
» Many unkept promises, but USTR sees progress in China’s trade commitments
To read the full story,
subscribe
or
sign in
.
Many unkept promises, but USTR sees progress in China’s trade commitments
Jan. 26, 2021
By
Mari Serebrov
When it comes to leveling the playing field for foreign-based biopharma and medical device companies, China has made a lot of promises, but delivering on those promises is what matters.
BioWorld Asia
Drugs
Medical devices and technologies
Regulatory
China
U.S.